Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis—in vitro and in vivo
- 6 January 2021
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 394 (6) , 1263-1274
Abstract
To determine whether sophocarpine (SC) can enhance the inhibiting effect of oxaliplatin on colorectal cancer (CRC) liver metastasis (CRCLM)—in vitro and in vivo. The inhibitory effect of SC and/or oxaliplatin on the proliferation, invasion, and migration of CRC cells was determined by CCK-8, MTT, wound healing migration, and transwell assay. Western blot and immunohistochemistry were used to evaluate the inhibitory effect of SC and/or oxaliplatin on the epithelial-mesenchymal transition (EMT) process. Nude mouse models of human CRCLM were established to test the anti-metastasis effect of SC and oxaliplatin in the single or combined form. SC exerted an inhibitory effect on the proliferation, invasion, and migration of CRC cells both in vitro and in vivo. The combination index of SC and oxaliplatin was 0.58. In addition, the inhibitory effect of SC in combination with oxaliplatin was found to be significantly stronger compared with that mediated by either SC or oxaliplatin alone, suggesting that SC can effectively enhance the inhibitory effect of oxaliplatin on CRCLM both in vitro and in vivo. SC was also revealed to reverse EMT process in cell lines and tissues, as reflected by the observed downregulation of N-cadherin and vimentin expression and the upregulation of E-cadherin expression. Taken together, data from the present study suggest that SC administration can inhibit CRC cell proliferation, invasion, migration, and EMT, while enhancing the inhibitory effects of oxaliplatin both in vitro and in vivo. These findings indicate (that) SC to be a promising anti-metastasis agent for CRCLM.Keywords
Funding Information
- Liaoning Provincial Natural Science Foundations of China (201602037)
This publication has 43 references indexed in Scilit:
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Multilayer control of the EMT master regulatorsOncogene, 2013
- Transwell® Invasion Assays2011
- Chemosensitization of tumors by resveratrolAnnals of the New York Academy of Sciences, 2011
- Synthesis and in vitro inhibitory activity of matrine derivatives towards pro-inflammatory cytokinesBioorganic & Medicinal Chemistry Letters, 2010
- Anti-nociceptive and anti-inflammatory activity of sophocarpineJournal of Ethnopharmacology, 2009
- Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: One institution's experienceWorld Journal of Gastroenterology, 2008
- Simultaneous quantification of oxysophocarpine and its active metabolite sophocarpine in rat plasma by liquid chromatography/mass spectrometry for a pharmacokinetic studyBiomedical Chromatography, 2007
- Antibody-Mediated p53 Protein Therapy Prevents Liver MetastasisIn vivoCancer Research, 2007
- Wound-Healing Assay2005